BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 15297940)

  • 1. Molecular biology of upper gastrointestinal malignancies.
    Lin J; Beerm DG
    Semin Oncol; 2004 Aug; 31(4):476-86. PubMed ID: 15297940
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased expression of the cyclin D1 gene in Barrett's esophagus.
    Arber N; Lightdale C; Rotterdam H; Han KH; Sgambato A; Yap E; Ahsan H; Finegold J; Stevens PD; Green PH; Hibshoosh H; Neugut AI; Holt PR; Weinstein IB
    Cancer Epidemiol Biomarkers Prev; 1996 Jun; 5(6):457-9. PubMed ID: 8781742
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CpG island hypermethylation in progression of esophageal and gastric cancer.
    Sato F; Meltzer SJ
    Cancer; 2006 Feb; 106(3):483-93. PubMed ID: 16362978
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Barrett's esophagus: disregulation of cell cycling and intercellular adhesion in the metaplasia-dysplasia-carcinoma sequence.
    Tselepis C; Perry I; Jankowski J
    Digestion; 2000; 61(1):1-5. PubMed ID: 10671768
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cellular and molecular mechanisms responsible for progression of Barrett's metaplasia to esophageal carcinoma.
    Beilstein M; Silberg D
    Gastroenterol Clin North Am; 2002 Jun; 31(2):461-79, ix. PubMed ID: 12134613
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative Molecular Analyses of Esophageal Squamous Cell Carcinoma, Esophageal Adenocarcinoma, and Gastric Adenocarcinoma.
    Salem ME; Puccini A; Xiu J; Raghavan D; Lenz HJ; Korn WM; Shields AF; Philip PA; Marshall JL; Goldberg RM
    Oncologist; 2018 Nov; 23(11):1319-1327. PubMed ID: 29866946
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytokeratin expression patterns in noncardia, intestinal metaplasia-associated gastric adenocarcinoma: implication for the evaluation of intestinal metaplasia and tumors at the esophagogastric junction.
    Shen B; Ormsby AH; Shen C; Dumot JA; Shao YW; Bevins CL; Gramlich TL
    Cancer; 2002 Feb; 94(3):820-31. PubMed ID: 11857318
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinicopathological study of early adenocarcinoma of the gastric cardia: comparison with early adenocarcinoma of the distal stomach and esophagus.
    Tajima Y; Nakanishi Y; Yoshino T; Kokawa A; Kusano M; Shimoda T
    Oncology; 2001; 61(1):1-9. PubMed ID: 11474241
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathology of upper gastrointestinal malignancies.
    Sarbia M; Becker KF; Höfler H
    Semin Oncol; 2004 Aug; 31(4):465-75. PubMed ID: 15297939
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differences in the molecular biology of adenocarcinoma of the esophagus, gastric cardia, and upper gastric third.
    Lehmann K; Schneider PM
    Recent Results Cancer Res; 2010; 182():65-72. PubMed ID: 20676871
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Barrett's esophagus: an overview of the molecular biology.
    Aldulaimi D; Jankowski J
    Dis Esophagus; 1999; 12(3):177-80. PubMed ID: 10631908
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic and Epigenetic Alterations in Barrett's Esophagus and Esophageal Adenocarcinoma.
    Kaz AM; Grady WM; Stachler MD; Bass AJ
    Gastroenterol Clin North Am; 2015 Jun; 44(2):473-89. PubMed ID: 26021206
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Carditis, intestinal metaplasia and adenocarcinoma of oesophagogastric junction.
    Conio M; Filiberti R; Blanchi S; Giacosa A
    Eur J Cancer Prev; 2001 Dec; 10(6):483-7. PubMed ID: 11916346
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The molecular biology of esophageal adenocarcinoma.
    Koppert LB; Wijnhoven BP; van Dekken H; Tilanus HW; Dinjens WN
    J Surg Oncol; 2005 Dec; 92(3):169-90. PubMed ID: 16299787
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The diagnosis and management of Barrett's esophagus.
    DeMeester SR; DeMeester TR
    Adv Surg; 1999; 33():29-68. PubMed ID: 10572561
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypermethylation of the AKAP12 promoter is a biomarker of Barrett's-associated esophageal neoplastic progression.
    Jin Z; Hamilton JP; Yang J; Mori Y; Olaru A; Sato F; Ito T; Kan T; Cheng Y; Paun B; David S; Beer DG; Agarwal R; Abraham JM; Meltzer SJ
    Cancer Epidemiol Biomarkers Prev; 2008 Jan; 17(1):111-7. PubMed ID: 18199717
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Despite shared susceptibility loci, esophageal squamous cell carcinoma embraces more familial cancer than gastric cardia adenocarcinoma in the Taihang Mountains high-risk region of northern central China.
    Wen DG; Yang Y; Wen XD; Shan BE
    Chin Med J (Engl); 2013 Jan; 126(1):55-60. PubMed ID: 23286478
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Carcinogenesis of Barrett's esophagus].
    Endo T; Sugawara N; Shinomura Y
    Nihon Rinsho; 2005 Aug; 63(8):1357-61. PubMed ID: 16101221
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Primary adenocarcinomas of lower esophagus, esophagogastric junction and gastric cardia: in special reference to China.
    Wang LD; Zheng S; Zheng ZY; Casson AG
    World J Gastroenterol; 2003 Jun; 9(6):1156-64. PubMed ID: 12800215
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic alterations in Barrett's esophagus and esophageal adenocarcinoma.
    Dinjens WN
    Minerva Chir; 2002 Dec; 57(6):733-52. PubMed ID: 12592217
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.